Alembic Pharmaceuticals Faces Stabilization Amid Mixed Technical and Financial Signals
Alembic Pharmaceuticals has experienced a recent evaluation adjustment, influenced by changes in technical indicators and market dynamics. The company's performance metrics indicate stabilization, with mixed signals from various technical analyses. Despite facing challenges in operating profit and stock returns, Alembic demonstrates a strong capacity to manage its debt.
Alembic Pharmaceuticals has recently undergone an adjustment in evaluation, reflecting shifts in its technical indicators and overall market position. The stock's technical trend has transitioned from a mildly bullish stance to a sideways movement, indicating a period of stabilization in its performance metrics.In terms of technical analysis, the MACD readings for both weekly and monthly periods are showing mildly bearish signals, while the Bollinger Bands present a mixed picture with weekly indicators remaining bullish and monthly indicators leaning bearish. The moving averages indicate a mildly bullish trend on a daily basis, yet the KST and Dow Theory metrics suggest a mildly bearish outlook in the weekly context.
Financially, Alembic Pharmaceuticals has reported a flat performance for the quarter ending June 2025, with operating profit declining at an annual rate over the past five years. The company has also experienced a notable drop in stock returns over the past year, underperforming against broader market indices. Despite these challenges, Alembic maintains a strong ability to service its debt, supported by a low Debt to EBITDA ratio.
Overall, the recent evaluation adjustment reflects a complex interplay of technical trends and financial metrics for Alembic Pharmaceuticals, highlighting the company's current market dynamics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
